Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Deloitte
Harvard Business School
Mallinckrodt
Fuji
Accenture
Express Scripts
Queensland Health
Fish and Richardson
AstraZeneca

Generated: August 19, 2017

DrugPatentWatch Database Preview

BUTAZOLIDIN Drug Profile

« Back to Dashboard

What is the patent landscape for Butazolidin, and what generic Butazolidin alternatives are available?

Butazolidin is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in BUTAZOLIDIN is phenylbutazone. There are nine drug master file entries for this compound. Additional details are available on the phenylbutazone profile page.

Summary for Tradename: BUTAZOLIDIN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list65
Patent Applications: see list7,949
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUTAZOLIDIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
BUTAZOLIDIN
phenylbutazone
CAPSULE;ORAL008319-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
BUTAZOLIDIN
phenylbutazone
TABLET;ORAL008319-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Covington
Cantor Fitzgerald
Harvard Business School
Citi
Moodys
Fuji
Federal Trade Commission
Chubb
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot